244 related articles for article (PubMed ID: 20352150)
1. Homocysteine and arterial thrombosis: Challenge and opportunity.
Di Minno MN; Tremoli E; Coppola A; Lupoli R; Di Minno G
Thromb Haemost; 2010 May; 103(5):942-61. PubMed ID: 20352150
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinaemia and atherothrombosis.
Cattaneo M
Ann Med; 2000 Dec; 32 Suppl 1():46-52. PubMed ID: 11209982
[TBL] [Abstract][Full Text] [Related]
3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases.
Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M
Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738
[TBL] [Abstract][Full Text] [Related]
4. Is plasma homocysteine a modifiable risk factor for stroke?
Hankey GJ
Nat Clin Pract Neurol; 2006 Jan; 2(1):26-33. PubMed ID: 16932518
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine, coagulation, platelet function, and thrombosis.
Coppola A; Davi G; De Stefano V; Mancini FP; Cerbone AM; Di Minno G
Semin Thromb Hemost; 2000; 26(3):243-54. PubMed ID: 11011842
[TBL] [Abstract][Full Text] [Related]
6. Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events. The Canadian Task Force on Preventive Health Care.
Booth GL; Wang EE
CMAJ; 2000 Jul; 163(1):21-9. PubMed ID: 10920726
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine and cardiovascular disease: a review of the evidence.
Wierzbicki AS
Diab Vasc Dis Res; 2007 Jun; 4(2):143-50. PubMed ID: 17654449
[TBL] [Abstract][Full Text] [Related]
8. Hyperhomocysteinemia: an additional cardiovascular risk factor.
Fanapour PC; Yug B; Kochar MS
WMJ; 1999 Dec; 98(8):51-4. PubMed ID: 10639897
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease.
Fimognari FL; Loffredo L; Di Simone S; Sampietro F; Pastorelli R; Monaldo M; Violi F; D'Angelo A
Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):654-9. PubMed ID: 19282159
[TBL] [Abstract][Full Text] [Related]
10. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients.
Suliman ME; Lindholm B; Bárány P; Qureshi AR; Stenvinkel P
Semin Dial; 2007; 20(6):523-9. PubMed ID: 17991198
[TBL] [Abstract][Full Text] [Related]
12. Plasma total homocysteine: instigator or indicator of cardiovascular disease?
Moat SJ
Ann Clin Biochem; 2008 Jul; 45(Pt 4):345-8. PubMed ID: 18583617
[TBL] [Abstract][Full Text] [Related]
13. [Homocysteine. The cardiovascular risk factor of the next millennium?].
Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
[TBL] [Abstract][Full Text] [Related]
14. [Hyperhomocysteinemia as a risk factor for venous thrombosis].
Willems HP; den Heijer M; Blom HJ; Gerrits WB; Rosendaal FR; Bos GM
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):552-6. PubMed ID: 10321272
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine and thrombosis: from basic science to clinical evidence.
Undas A; Brozek J; Szczeklik A
Thromb Haemost; 2005 Nov; 94(5):907-15. PubMed ID: 16363230
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine-lowering vitamins do not lower plasma S-adenosylhomocysteine in older people with elevated homocysteine concentrations.
Green TJ; Skeaff CM; McMahon JA; Venn BJ; Williams SM; Devlin AM; Innis SM
Br J Nutr; 2010 Jun; 103(11):1629-34. PubMed ID: 20089204
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients.
Nakhoul F; Abassi Z; Plawner M; Khankin E; Ramadan R; Lanir N; Brenner B; Green J
Isr Med Assoc J; 2004 Apr; 6(4):213-7. PubMed ID: 15115259
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: hyperhomocysteinemia is an indicator of oxidant stress.
Hoffman M
Med Hypotheses; 2011 Dec; 77(6):1088-93. PubMed ID: 21963358
[TBL] [Abstract][Full Text] [Related]
19. Association of B vitamins status and homocysteine levels in elderly Taiwanese.
Chen KJ; Pan WH; Yang FL; Wei IL; Shaw NS; Lin BF
Asia Pac J Clin Nutr; 2005; 14(3):250-5. PubMed ID: 16169836
[TBL] [Abstract][Full Text] [Related]
20. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
